Screening and diagnosis
Blog
Our series of blog posts
Our blogs are written by health professionals who have expertise in the field of prostate and prostate cancer. You can therefore be assured that the information provided is precise and accurate. The many topics covered are intended to help people better understand the effects of the disease, treatment options and how to improve their quality of life.
Soon a diagnosis by simple blood test?
Diagnosing (not screening) prostate cancer by a simple blood test: this is the project on which works Dr. Catherine Alix-Panabières and a team of European researchers at CHU Montpellier. A method that would be more reliable and less invasive than the diagnosis by a biopsy of prostate tissue. With 12 men diagnosed daily in Quebec […]
Aromatherapy to treat prostate cancer?
Researchers at Duke University in North Carolina have shown that an olfactory receptor plays a critical role in the progression of prostate cancer. This discovery suggests that an approach that aims to block the olfactory receptor with specific molecules, or perhaps even with specific scents – aromatherapy – could become a new therapeutic pathway to fight […]
A microchip for early detection of cancer wins awards
Developed by students from western Turkey, the microchip has won quite prestigious awards in the United States and Europe. Berna Akdeniz and Leyla Al Masoud – chip processors in Izmir, western Turkey – decided to study early diagnosis of cancer in 2016 and a year later, the duo developed a microfluidic chip for early detection of […]
PSA and screening: 2012 guidelines updated in the US
The US Preventive Services Task Force is now recommending increased screening for prostate cancer, a move that reverses previous guidelines that recommended against routine prostate cancer screening. This week, the US Task Force updated its 2012 position on prostate cancer screening recommending that clinicians should selectively offer or provide periodic prostate-specific antigen (PSA)–based screening for […]
Scientists uncover 80 potential lines of attack against prostate cancer
UK researchers obtained genetic information from the tumours of 112 men with prostate cancer and pooled it with data from other studies, including The Cancer Genome Atlas (TCGA)1 study from the National Institutes of Health (NIH), in which participated the PROCURE Biobank. Published in the prestigious scientific journal Cell in November 2015, The Cancer Genome […]
Why should I participate in a clinical trial?
You may be comforted to know that doctors and scientists are working diligently at finding new and better ways to treat, prevent, and screen for prostate cancer as well as to enhance the quality of life for prostate cancer patients. This work is done through clinical trials. What is a clinical trial? After a new […]
